Pfizer remains an attractive capital return play with a 10X P/E ratio, despite concerns about post-COVID revenue declines. Read more about PFE stock here.

A federal judge has dismissed a lawsuit by a New York family who claimed the Department of Defense misled Americans into ...

The autumn wave of coronavirus is sweeping across Germany. Those affected mainly suffer from coughs, colds, sore throats and ...

Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...

Free rapid tests for COVID-19 are now available to order online.As of Friday, Sept. 27, every American household may order four nasal swab tests through the Department of Health and Human Services ...

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...

A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

BioNTech's updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus. The ...

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...